
Please try another search
Align Technology, Inc. (NASDAQ:ALGN) recently inked a deal to acquire Germany-based privately held exocad Global Holdings GmbH. exocad is a global pioneer in the dental CAD/CAM software space and specializes in offering fully-integrated workflows to dental laboratories and practices. It boasts an extensive network of customers, partners and resellers across 150 countries.
This acquisition should widen Align Technology’s reach in digital dentistry by enhancing adoption of Invisalign treatment among more than 300 million potential patients globally.
More About the Acquisition
The takeover is likely to bolster Align Technology’s digital platform that provides innovative tools and features for diagnostic, restorative, implant and orthodontic workflows. Once the acquisition is completed, exocad’s expertise in restorative dentistry, implantology, guided surgery and smile design will be integrated into Align Technology’s portfolio of Invisalign and iTero digital solutions.
This acquisition deal comes as a continuation of the collaboration efforts between Align Technology and exocad that initiated in 2017 with the integration of Align’s iTero intraoral scanners and exocad Chairside CAD software.
Per the terms of the deal, Align Technology will pay nearly 376 million euros in cash to acquire exocad. The deal is expected to close during the second quarter of 2020.
Market Prospects
Per a report by Technavio, the global dental CAD-CAM market is anticipated to see a CAGR of 8.15% during the forecast period of 2017-2021.Hence the acquisition deal is well-timed.
Recent Development
In September 2019, Align Technology inked a global distribution deal with Zimmer Biomet (NYSE:ZBH) Dental business to boost its portfolio of iTero Element suite of intraoral scanners.This deal should aid Align Technology to expand the reach of its iTero scanners and services in the growing digital restorative market. The collaboration will also offer customers of Zimmer Biomet Dental the opportunity to access Invisalign clear aligners through the iTero platform.
Competitive Scenario
The digital dentistry market is highly competitive with two of the prominent dental CAD/CAM market vendors being Danaher Corporation (NYSE:DHR) and DENTSPLY SIRONA (NASDAQ:XRAY) .
Danaher cemented its position within the global dental CAD/CAM market with the acquisition of Nobel Biocare in 2014.In a bid to strengthen its CAD-CAM-based dental unit, DENTSPLY acquired OraMetrix — a leading industry provider of innovative 3-D technology solutions — in 2018.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
As the digital economy starts to go online across businesses and the world, investors have to be aware of the companies and services that will be at the forefront of this...
Wall Street Indexes remain under pressure today but have held above the lows we saw on Tuesday as the Trump administration tariffs came into force. The announcement of tariffs on...
These stocks provide a compelling case as safe-haven stocks in the face of an escalating trade war. Each company operates within sectors that are relatively resilient to economic...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.